insights_auto
Why is SUPN up 4.55%?
Dive Deeperchevron_right
SUPN:NASDAQ
Supernus Pharmaceuticals Inc
$44.60
arrow_upward
+4.55%(+1.94) 1D
$44.60
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 28, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SUPN...
Open
$42.59
High
$44.61
Low
$42.38
Mkt. cap
2.60B
Avg. vol.
601.25K
Volume
0.00
52-wk high
$59.68
52-wk low
$40.52
EPS
-$1.91
Beta
0.56
Shares outstanding
58.22M
No. of employees
778
Open
$42.59
High
$44.61
Low
$42.38
Mkt. cap
2.60B
Avg. vol.
601.25K
Volume
0.00
52-wk high
$59.68
52-wk low
$40.52
EPS
-$1.91
Beta
0.56
Shares outstanding
58.22M
No. of employees
778
News stories
From web sources and news partners
GuruFocus
·
6 hours ago
Is Supernus Pharmaceuticals Inc (SUPN) Overvalued After 4.5% Ral
Zacks
·
19 hours ago
Can Biogen's Growth Portfolio Maintain Its Lead Over Legacy MS Drugs?
StockStory
·
2 days ago
2 Growth Stocks to Add to Your Roster and 1 We Question
About Supernus Pharmaceuticals Inc
CEOJack A. Khattar
Employees778
Founded2005
HeadquartersRockville, Maryland, United States
SectorPharmaceutical industry
Websitesupernus.com